Article
No significant association between genetic variants in 7 candidate genes and response to methylphenidate treatment in adult patients with ADHD.
Journal of clinical psychopharmacology - 1 Dec 2012
Contini Verônica, Victor Marcelo M, Bertuzzi Guilherme P, Salgado Carlos A I, Picon Felipe A, Grevet Eugenio H, Rohde Luis A, Belmonte-de-Abreu Paulo, Bau Claiton H D
Abstract excerpt
Results from pharmacogenetic investigations of methylphenidate (MPH) response in patients with ADHD are still inconsistent, especially among adults. This study investigates the role of genetic variants (SLC6A4, HTR1B, TPH2, DBH, DRD4, COMT, and SNAP25) in the response to MPH in a sample of 164 adults. Genes were chosen owing to previous evidence for an influence in ADHD susceptibility. No significant differences...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
